SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 129 filers reported holding SCICLONE PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $3,624,000 | +160.3% | 329,495 | +117.5% | 0.01% | +200.0% |
| Q4 2015 | $1,392,000 | -50.6% | 151,471 | -62.7% | 0.00% | -60.0% |
| Q3 2015 | $2,815,000 | +66.7% | 405,556 | +135.9% | 0.01% | +66.7% |
| Q2 2015 | $1,689,000 | -1.9% | 171,893 | -11.5% | 0.00% | 0.0% |
| Q1 2015 | $1,721,000 | -54.6% | 194,128 | -55.1% | 0.00% | -57.1% |
| Q4 2014 | $3,788,000 | +116.5% | 432,422 | +70.2% | 0.01% | +133.3% |
| Q3 2014 | $1,750,000 | +246.5% | 254,034 | +142.0% | 0.00% | +200.0% |
| Q2 2014 | $505,000 | +5.6% | 104,974 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $478,000 | -9.0% | 104,974 | -4.8% | 0.00% | 0.0% |
| Q4 2013 | $525,000 | -38.6% | 110,237 | -32.9% | 0.00% | -50.0% |
| Q3 2013 | $855,000 | +809.6% | 164,363 | +766.6% | 0.00% | – |
| Q2 2013 | $94,000 | – | 18,966 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sensato Investors LLC | 1,564,682 | $10,859,000 | 2.03% |
| Matarin Capital Management, LLC | 274,291 | $1,903,580,000 | 0.39% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 87,524 | $607,417,000 | 0.36% |
| TFS CAPITAL LLC | 323,415 | $2,245,000 | 0.22% |
| Nantahala Capital Management | 170,218 | $1,181,000 | 0.16% |
| Ativo Capital Management LLC | 74,338 | $592,000 | 0.16% |
| MENTA CAPITAL LLC | 111,985 | $777,000 | 0.12% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 229,891 | $1,595,000 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 270,888 | $1,880,000 | 0.09% |
| BOOTHBAY FUND MANAGEMENT, LLC | 25,644 | $178,000 | 0.08% |